MelliCell is a pre-clinical biotechnology company with innovative technology to develop therapeutics for reversing obesity and type 2 diabetes by targeting fat cells.
The Company was founded June 2020 and has its headquarters in Newton, Mass.
The Company was founded June 2020 and has its headquarters in Newton, Mass.
Speaker
